Buy stocks
Invest and track all your stocks in one place.
Natco Pharma LtdNSE: NATCOPHARM
NSE: NATCOPHARM
₹997.10
+3.40
(7:00 am IST)
+0.3%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹997.10
Today’s high
₹1,042.95
Today’s low
₹993.85
52W high
₹1,107.85
52W low
₹520.60
1Y
77.4%
PE
14.07
PB
3.37
EPS (TTM)
39.18
Dividend yield
0.5%
5Y
12.2%
Market cap
₹17,834.0 Cr
Volume
45,503
Average volume
52,923
Insights
NATCOPHARM price is above its 200 day moving average
NATCOPHARM PE is in the low end of its range over the past 2 years
In beta. Send feedback here.
Compare with other stock
Price
₹1,692.30
₹1,110.30
₹997.10
₹1,568.00
₹6,403.30
₹3,497.00
1D
+3.6%
+3.2%
+0.3%
+1.1%
+2.6%
-0.3%
1Y
+155.4%
+141.3%
+77.4%
+62.2%
+44.3%
+22.7%
PE
43.19
23.50
14.07
42.26
20.44
67.11
PB
5.82
2.31
3.37
6.29
3.98
7.32
EPS
39.18
47.24
70.88
37.10
313.29
52.11
Market cap
Large
Large
Large
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2022
Revenue
₹2,696.9 Cr
Net income
₹715.3 Cr
See stock holdings
Top institutional holders
Mirae Asset Global Inv (India) Pvt. Ltd
2.66%
Aditya Birla Sun Life AMC Ltd
1.67%
Vanguard Group Inc
1.59%
TATA AIA Life Insurance Company Limited
1.26%
ICICI Prudential Asset Management Company Limited
1.25%
Top mutual fund holders
Mirae Asset Emerging Bluechip
1.46%
Mirae Asset Large & Midcap Fund
1.46%
Mirae Asset Midcap Fund
1.07%
Quant Small Cap Fund
1.05%
ICICI Prudential India Opportunities Fd
0.85%
About Natco Pharma
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.
Company address
Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, 500034
Key executives
Name
Title
Age
Mr. Rajeev Nannapaneni
CEO/Director
NA
Mr. P.S.R.K. Prasad
Director/Executive VP, Divisional
NA
Dr. Pavan Bhat
Director/Executive VP, Divisional
NA
Mr. V.C. Nannapaneni
Director/Managing Director
NA
Dr. Linga Rao Donthineni
Director/President, Divisional
NA

FAQs

How to Buy Natco Pharma Ltd Stock?
What is the Share Price of Natco Pharma Ltd?
What is the Market Cap of Natco Pharma Ltd?
In which sector / industry does Natco Pharma Ltd operate?
What was the revenue of Natco Pharma Ltd?
What is the PE ratio of Natco Pharma Ltd?
What is the 52 week high price of Natco Pharma Ltd?
What is the 52 week low price of Natco Pharma Ltd?
Can fractional shares of Natco Pharma Ltd be purchased?